2 - BACTERIOWEB

2 - BACTERIOWEB 2 - BACTERIOWEB

bacterioweb.univ.fcomte.fr
from bacterioweb.univ.fcomte.fr More from this publisher
06.08.2013 Views

Expression System NorA in S. aureus – Constitutive or slightly inducible by FQs in wild-type strains – Increased by mutations in the promoter region of norA or in other loci Substrates – Identical to those of pump Bmr in Bacillus subtilis – Specificity related to C-7 residue and hydrophobicity of C-8 residue Inhibitors – CCCP, nigericin, nigericin, reserpin, reserpin, verapamil, verapamil, omprazole, omprazole lanzoprazole 16

System NorA in S. aureus Antibiotics Wild-type NorA+++ NorA- Nalidixic acid 25 - 125 100 - >1000 nd Norfloxacin 0.8 - 1.6 50 - 80 0.2 - 0.3 Ciprofloxacin 0.25 - 0.7 6 0.1 - 0.2 Ofloxacin 0.2 - 0.5 1.5 - 3 0.4 Pefloxacin 0.5 12.5 nd Sparfloxacin 0.1 0.2 0.1 Cetrimide 0.4 6.5 nd Benzalkonium 1 3 nd Ethidium bromide 5 - 6.5 25 0.5 17 (CMI µg/mL

System NorA in S. aureus<br />

Antibiotics Wild-type NorA+++ NorA-<br />

Nalidixic acid 25 - 125 100 - >1000 nd<br />

Norfloxacin 0.8 - 1.6 50 - 80 0.2 - 0.3<br />

Ciprofloxacin 0.25 - 0.7 6 0.1 - 0.2<br />

Ofloxacin 0.2 - 0.5 1.5 - 3 0.4<br />

Pefloxacin 0.5 12.5 nd<br />

Sparfloxacin 0.1 0.2 0.1<br />

Cetrimide 0.4 6.5 nd<br />

Benzalkonium 1 3 nd<br />

Ethidium bromide 5 - 6.5 25 0.5<br />

17<br />

(CMI µg/mL

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!